课题基金 / 基金详情

Latent virus and HIV-1 specific immunity in LTNPs

Latent virus and HIV-1 specific immunity in LTNPs
LTNP 中的潜伏病毒和 HIV-1 特异性免疫
批准号:
6450960
负责人:
JOEL N BLANKSON
金额:
$11.53万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-08-01 至 2007-07-31

项目摘要

项目成果

JOEL N BLANKSON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dr. Blankson is an infectious diseases fellow at the Johns Hopkins University and has spent the last three years working with his mentor, Dr. Robert Siliciano on HIV-1 latency and HIV-1 specific immunity. Through this award, Dr. Blankson hopes to conduct basic science research relating to these topics as a faculty member in infectious diseases at Johns Hopkins. He plans to characterize the latent virus isolates and HIV-1 specific immune responses of HIV-1 infected patients who spontaneously control viral replication. His hypothesis is that these patients form a heterogeneous group; some patients are infected with attenuated virus, others are infected with fully pathogenic virus but are able to control viral replication with vigorous HIV-1 specific immune responses. He plans to isolate latent virus from these patients and then to perform genotypic and phenotypic studies to assess the replication fitness of these isolates. He also plans to characterize their HIV-1 specific immune response with a special focus on identifying CD4+ and CD8+ T cell epitopes. The sequence of autologous latent virus at these epitopes will be analyzed for evidence of selective pressure exerted by the immune system. Dr. Blankson will attend basic immunology and virology seminars as well as clinical medicine and infectious diseases conferences. This along with the excellent mentorship of Dr. Siliciano, and the supportive environment of the Johns Hopkins University will provide Dr. Blankson with the skills he needs to develop into an independent clinician and basic scientist researcher in HIV-1 pathogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Eradication of clonally expanded CD4+ T cells
  • 批准号:
    10621808
  • 项目类别:
  • 资助金额:
    $20.47万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
Eradication of clonally expanded CD4+ T cells
  • 批准号:
    10548015
  • 项目类别:
  • 资助金额:
    $24.56万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
mRNA vaccine responses in PLWH
  • 批准号:
    10402541
  • 项目类别:
  • 资助金额:
    $24.56万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
mRNA vaccine responses in PLWH
  • 批准号:
    10687989
  • 项目类别:
  • 资助金额:
    $20.47万
  • 财政年份:
    2022
  • 负责人:
    JOEL N BLANKSON
  • 依托单位:
海外基金